Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53

Genes and Development

Volumn 14, Issue 3, 2000, Pages 278-288

  Chehab, Nabil H ^a,b   Malikzay, Asra ^a   Appel, Michael ^a   Halazonetis, Thanos D ^a,b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ATM; Checkpoints; Chk2; DNA damage; hCds1; p53

Indexed keywords

PROTEIN P53;

ARTICLE; CELL CYCLE G1 PHASE; DNA DAMAGE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; SACCHAROMYCES; TRANSCRIPTION REGULATION;

DNA DAMAGE; G1 PHASE; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE;

EID: 0034142325     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Agarwal, M.L., A. Agarwal, W.R. Taylor, O. Chernova, Y. Sharma, and G.R. Stark. 1998. A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc. Natl. Acad. Sci. 95: 14775-14780.
2. Ashcroft, M., M.H. Kubbutat, and K.H. Vousden. 1999. Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol. 19: 1751-1758.
3. Banin, S., L. Moyal, S. Shieh, Y. Taya, C.W. Anderson, L. Chessa, N.I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677.
4. Bell, D.W., J.M. Varley, T.E. Szydlo, D.H. Kang, D.C. Wahrer, K.E. Shannon, M. Lubratovich, S.J. Verselis, K.J. Isselbacher, J.F. Fraumeni et al. 1999. Heterozygous germline hChk2 mutations in Li-Fraumeni syndrome. Science 286: 2528-2531.
5. Bentley, N.J., D.A. Holtzman, G. Flaggs, K.S. Keegan, A. DeMaggio, J.C. Ford, M. Hoekstra, and A.M. Carr. 1996. The Schizosaccharomyces pombe rad3 checkpoint gene. EMBO J. 15: 6641-6651.
6. Blades, J. P. and T. Hupp. 1998. DNA damage triggers DRB-resistant phosphorylation of p53 at the CKII site. Oncogene 17: 1045-1052.
7. Blasina, A., de I.V. Weyer, M.C. Laus, W.H. Luyten, A.E. Parker, and C.H. McGowan. 1999. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr. Biol. 9: 1-10.
8. Blattner, C., E. Tobiasch, M. Litfen, H.J. Rahmsdorf, and P. Herrlich. 1999. DNA damage induced p53 stabilization: No indication for an involvement of p53 phosphorylation. Oncogene 18: 1723-1732.
9. Boddy, M.N., B. Furnari, O. Mondesert, and P. Russell. 1998. Replication checkpoint enforced by kinases Cds1 and Chk1. Science 280: 909-912.
10. Brondello, J.M., M.N. Boddy, B. Furnari, and P. Russell. 1999. Basis for the checkpoint signal specificity that regulates Chk1 and Cds1 protein kinases. Mol. Cell. Biol. 19: 4262-4269.
11. Brown, A.L., C.H. Lee, J.K. Schwarz, N. Mitiku, H. Piwnica-Worms, and J.H. Chung. 1999. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. 96: 3745-3750.
12. 1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54: 5054-5058.
13. Canman, C.E., D.S. Lim, K.A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M.B. Kastan, and J.D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679.
14. Chehab, N.H., A. Malikzay, E.S. Stavridi, and T.D. Halazonetis. 1999. Phosphorylation of Ser-20 mediates stabilization of p53 in response to DNA damage. Proc. Natl. Acad. Sci. 96: 13777-13782.
15. Chen, C.Y., I. Hall, T.J. Lansing, T.M. Gilmer, T.D. Tlsty, and M.B. Kastan. 1996. Separate pathways for p53 induction by ionizing radiation and N-(phosphonoacetyl)-L-aspartate. Cancer Res. 56: 3659-3662.
16. Chernov, M.V. and G.R. Stark. 1997. The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate. Oncogene 14: 2503-2510.
17. Cimprich, K.A., T.B. Shin, C.T. Keith, and S.L. Schreiber. 1996. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl. Acad. Sci. 93: 2850-2855.
18. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
19. Cohen-Fix, O. and D. Koshland. 1997. The anaphase inhibitor of Saccharomyces cerevisiae Pdslp is a target of the DNA damage checkpoint pathway. Proc. Natl. Acad. Sci. 94: 14361-14366.
20. Eisenberg, S.P., R.J. Evans, W.P. Arend, E. Verderber, M.T. Brewer, C.H. Hannum, and R.C. Thompson. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343: 341-346.
21. Elledge, S.J. 1996. Cell cycle checkpoints: Preventing an identity crisis. Science 274: 1664-1672.
22. Flaggs, G., A.W. Plug, K.M. Dunks, K.E. Mundt, J.C. Ford, M.R. Quiggle, E.M. Taylor, C.H. Westphal, T. Ashley, M.F. Hoekstra et al. 1997. Atm-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes. Curr. Biol. 7: 977-986.
23. Fritsche, M., C. Haessler, and G. Brandner. 1993. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8: 307-318
24. Furnari, B., N. Rhind, and P. Russell. 1997. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277: 1495-1497.
25. Haapajarvi, T., K. Pitkanen, M. Tsubari, and M. Laiho. 1997. p53 transactivation and protein accumulation are independently regulated by UV light in different phases of the cell cycle. Mol. Cell. Biol. 17: 3074-3080.
26. Halazonetis, T.D. and Y. Shiloh. 1999. Many faces of ATM: Eighth international workshop on ataxia-telangiectasia. Bioch. Bioph. Acta 1424: R45-R55.
27. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
28. Kapoor, M. and G. Lozano. 1998. Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc. Natl. Acad. Sci. 95: 2834-2837.
29. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
30. Kastan, M.B., Q. Zhan, W.S. el-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
31. Khanna, K.K. and M.F. Lavin. 1993. Ionizing radiation and UV induction of p53 protein by different pathways in ataxiatelangiectasia cells. Oncogene 8: 3307-3312.
32. Khanna, K.K., K.E. Keating, S. Kozlov, S. Scott, M. Gatei, K. Hobson, Y. Taya, B. Gabrielli, D. Chan, S.P. Lees-Miller et al. 1998. ATM associates with and phosphorylates p53: Mapping the region of interaction. Nat. Genet. 20: 398-400.
33. Knippschild, U., D.M. Milne, L.E. Campbell, A.J. DeMaggio, E. Christenson, M.F. Hoekstra, and D.W. Meek. 1997. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs. Oncogene 15: 1727-1736.
34. Kubbutat, M.H., S.N. Jones, and K.H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387: 299-303.
35. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. 89: 7491-7495.
36. Kussie, P.H., S. Gorina, V. Marechal, B. Elenbaas, J. Moreau, A.J. Levine, and N.P. Pavletich. 1996. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948-953.
37. Lain, S., C. Midgley, A. Sparks, E.B. Lane, and D.P. Lane. 1999. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp. Cell Res. 248: 457-472.
38. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
39. Li, C.Y., H. Nagasawa, W.K. Dahlberg, and J.B. Little. 1995. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene 11: 1885-1892.
40. Lindsay, H.D., D.J. Griffiths, R.J. Edwards, P.U. Christensen, J.M. Murray, F. Osman, N. Walworth, and A.M. Carr. 1998. S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe. Genes & Dev. 12: 382-395.
41. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes & Dev. 10: 934-947.
42. Liu, L., D.M. Scolnick, R.C. Trievel, H.B. Zhang, R. Marmorstein, T.D. Halazonetis, and S.L. Berger. 1999. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19: 1202-1209.
43. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
44. Lu, H., Y. Taya, M. Ikeda, and A.J. Levine. 1998. Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc. Natl. Acad. Sci. 95: 6399-6402.
45. Lu, X. and D.P. Lane. 1993. Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75: 765-778.
46. Lutzker, S.G. and A.J. Levine. 1996. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med. 2: 804-810.
47. Maltzman, W. and L. Czyzyk. 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4: 1689-1694.
48. Matsuoka, S., M. Huang, and S.J. Elledge. 1998. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282: 1893-1897.
49. Midgley, C.A. and D.P. Lane. 1997. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15: 1179-1189.
50. Momand, J., G.P. Zambetti, D.C. Olson, D. George, and A.J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
51. Muller-Tiemann, B.F., T.D. Halazonetis, and J.J. Elting. 1998. Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. Proc. Natl. Acad. Sci. 95: 6079-6084.
52. Nagasawa, H., P. Keng, C. Maki, Y. Yu, and J.B. Little. 1998. Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection. Cancer Res. 58: 2036-2041.
53. Navas, T.A., Y. Sanchez, and S.J. Elledge. 1996. RAD9 and DNA polymerase epsilon form parallel sensory branches for transducing the DNA damage checkpoint signal in Saccharomyces cerevisiae. Genes & Dev. 10: 2632-2643.
54. Palm, G.J., A. Zdanov, G.A. Gaitanaris, R. Stauber, G.N. Pavlakis, and A. Wlodawer. 1997. The structural basis for spectral variations in green fluorescent protein. Nat. Struct. Biol. 4: 361-365.
55. Roth, J., M. Dobbelstein, D.A. Freedman, T. Shenk, and A.J. Levine. 1998. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17: 554-564.
56. Sakaguchi, K., J.E. Herrera, S. Saito, T. Miki, M. Bustin, A. Vassilev, C.W. Anderson, and E. Appella. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes & Dev. 12: 2831-2841.
57. Sanchez, Y., B.A. Desany, W.J. Jones, Q. Liu, B. Wang, and S.J. Elledge. 1996. Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science 271: 357-360.
58. Sanchez, Y., C. Wong, R.S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms, and S.J. Elledge. 1997. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science 277: 1497-1501.
59. Sanchez, Y., J. Bachant, H. Wang, F. Hu, D. Liu, M. Tetzlaff, and S.J. Elledge. 1999. Control of the DNA damage checkpoint by Chk1 and Rad53 protein kinases through distinct mechanisms. Science 286: 1166-1171.
60. Savitsky, K., A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez et al. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753.
61. Shieh, S.Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334.
62. Shieh, S.Y., Y. Taya, and C. Prives. 1999. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 18: 1815-1823.
63. Shieh, S.Y., J. Ahn, K. Tamai, Y. Taya, and C. Prives. 2000. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes & Dev. 14: 289-300.
64. Sidorova, J.M. and L.L. Breeden. 1997. Rad53-dependent phosphorylation of Swi6 and down-regulation of CLN1 and CLN2 transcription occur in response to DNA damage in Saccharomyces cerevisiae. Genes & Dev. 11: 3032-3045.
65. Siliciano, J.D., C.E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M.B. Kastan. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes & Dev. 11: 3471-3481.
66. Stavridi, E.S., N.H. Chehab, L.C. Caruso, and T.D. Halazonetis. 1999. Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions. Protein Sci. 8: 1773-1779.
67. Sun, Z., D.S. Fay, F. Marini, M. Foiani, and D.F. Stern. 1996. Spk1/Rad53 is regulated by Mec1-dependent protein phosphorylation in DNA replication and damage checkpoint pathways. Genes & Dev. 10: 395-406.
68. Syljuasen, R.G., B. Krolewski, and J.B. Little. 1999. Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status. Cancer Res. 59: 1008-1014.
69. Tibbetts, R.S., K.M. Brumbaugh, J.M. Williams, J.N. Sarkaria, W.A. Cliby, S.Y. Shieh, Y. Taya, C. Prives, and R.T. Abraham. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes & Dev. 13: 152-157.
70. Tominaga, K., H. Morisaki, Y. Kaneko, A. Fujimoto, T. Tanaka, M. Ohtsubo, M. Hirai, H. Okayama, K. Ikeda, and M. Nakanishi. 1999. Role of human cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53. J. Biol. Chem. 274: 31463-31467.
71. Unger, T., T. Juven-Gershon, E. Moallem, M. Berger, R.V. Sionov, G. Lozano, M. Oren, and Y. Haupt. 1999. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18: 1805-1814.
72. Walworth, N.C. and R. Bernards. 1996. rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science 271: 353-356.
73. Waterman, M.J., E.S. Stavridi, J.L. Waterman, and T.D. Halazonetis. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19: 175-178.
74. Weinert, T. 1998. DNA damage and checkpoint pathways: Molecular anatomy and interactions with repair. Cell 94: 555-558.
75. Weinreich, M. and B. Stillman. 1999. Cdc7p-Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway. EMBO J. 18: 5334-5346.
76. Wieczorek, A.M., J.L. Waterman, M.J. Waterman, and T.D. Halazonetis. 1996. Structure-based rescue of common tumor-derived p53 mutants. Nat. Med. 2: 1143-1146.
77. Zeng, Y., K.C. Forbes, Z. Wu, S. Moreno, H. Piwnica-Worms, and T. Enoch. 1998. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature 395: 507-510.